The increase of serum Bcl‑2 concentration in moderate head injury outcome: The role of ACTH4‑10Pro8‑Gly9‑Pro10
Editorial Board
Asian Journal of Neurosurgery
HONORARY EDITOR IN CHIEF
Tetsuo Kanno
Fujita Health
University, Japan
EDITOR IN CHIEF
Yoko Kato
Fujita Health
University, Japan
EXECUTIVE EDITORS
Wai Hoe Ng
National
Neuroscience
Institute, Singapore
Atul Goel
K. E. M. Hospital,
India
Kostadin
Karagiozov
The Jikei University,
Japan
PUBLICATION & COORDINATING EDITOR
Abhishek Agrawal
Duke university and
medical center,
north carolina, USA
EDITORIAL ASSISTANT
Hiromi Peck Fujita Health University, Japan
EDITORIAL OFFICE:
Fujita Health University, Japan.
EDITORIAL BOARD:
Akira Ogawa
Gerardo
Katsuji Shima
Salman
Japan
Akira Teramoto
Japan
Ali Raja
Pakistan
Andrew H. Kaye
Australia
Atul Goel
India
Basant K. Misra
India
Basant Pant
Nepal
Batchuluun
Banzragch
Mongolia
Bob S. Carter
USA
Chandrashekar
E. Deopujari
India
Colvin Anaada
Samarasinge
Sri Lanka
Eka J.
Wahjoepramono
Indonesia
Endro Basuki
Indonesia
Fadzili Cheah
Abdullah
Malaysia
Feng Ling
China
Dizon
Legaspi
Philippines
Glavije
Amirjamshi
di
Pakistan
Hajime
Arai
Japan
Hee-Won
Jung
Korea
Hirotoshi
Sano
Japan
Im Sophorn
Cambodia
Imad N.
Kanaan
Saudi
Arabia
lvan Ng
Singapore
Iype
Cherian
Nepal
Jafri Malin
Dafuk HJ
Abdullah
Malaysia
Javaid
Iqbal
UAE
Jizong
Zhao
China
Julius July
Indonesia
Junichi
Mizuno
Japan
Kaoru
Kurisu
Japan
Japan
Liangfu Zhou
(WFNS:
second
delegate)
China
M. Necmettin
Pamir
Turkey
M.K. Kariev
Uzbekistan
Mehmet Zileli
Turkey
Marianne
Vonau
Australia
Michael
Lawton
USA
Moon-Chan
Kim
Korea
Mohsen Nouri
Iran
Muhammad
Anwar
Pakistan
Myat Thu
Myanmar
Nausher Alam
Bangladesh
Nho Vo Van
Vietnam
Nobuo
Hashimoto
Japan
Rahul Mally
India
Sharif
Pakistan
Suresh Nair
India
Takamasa
Kayama
Japan
Takaomi
Taira
Japan
Takeshi
Kawase
Japan
Tariq
Salahuddin
Pakistan
Toshiaki
Abe
Japan
Tsevegbat
Enkhbayar
Mongolia
Wai S. Poon
Hong Kong
Watanyoo
Prachayano
nt
Thailand
Yoichi
Katayama
Japan
YongKwang Tu
Taiwan
Yousef AI
Awadhi
Kuwait
Yuichi
Hirose
Japan
INTERNATIONAL ADVISORY BOARD:
Abass Amir Jamshidi
Iran
Abdeslam El
Khamlichi
Morocco
Ahmed Ammar
Saudi Arabia
Albert L. Rhoton
USA
Albino Bricolo
Italy
Alexander
N.Konovalov
Russia
Alexandru V. Ciurea
Romania
Ali F. Krisht
USA
Anil Nanda
USA
Apio Antunes
Brazil
Armando Basso
Argentina
Carolina Martins
Brazil
Chiristopher M.
Loftus
USA
Edward R. Laws Jr.
USA
Gail Rosseau
USA
Hamid Rahmat
Iran
Helmut Bertalanffy
Germany
Ibrahim Sbeih
Jordan
Jacques Brotchi
Belgium
James T. Rutka
Canada
Kazadi Kalangu
Zimbabwe
Laligam N.Sekhar
USA
Leonidas M. Quintana
Chile
Madjid Samii
Germany
Marcos Masini
Brazil
Maurice Choux
France
Moutaery, Khalaf
Al
Saudi Arabia
Nabil A. Rahman
Egypt
Ossama Al-Mefty
USA
Peter Black
USA
Richard Perrin
Canada
Robert F. Spetzler
USA
Roberto Heros
USA
Temitayo Shokunbi
Nigeria
Reviewer's List for AJNS
Abhishek Agrawal
Ajay Nand Jha
Ajith Thomas
Ali Krisht
Andrew Kaye
Anil Nanda
Apio Antunes
Ashok Kumar
Mahapatra
Atul Goel
Awadhesh Kumar
Jaiswal
Colvin Samarasinge
Chandrashekar E.
Deopujari
Edward R. Laws Jr.
Gerardo Legaspi
Gabriel Zada
Imad N. Kanaan
Ivan NG
Junichi Mizuno
Kai Frerichs
Ling Feng
Michael Lawton
Mitsuhiro Hasegawa
Mohsen Nouri
Muhammad Raji
Mahmud
Necmettin Pamir
Rakeshkumar Luhana
Suresh Nair
Wai Hoe NG
Yong-Kwang Tu
Yashbir Dewan
[Downloaded free from http://www.asianjns.org on Monday, August 31, 2015, IP: 114.125.9.86]
ORIGINAL ARTICLE
The increase of serum Bcl‑2 concentration in
moderate head injury outcome: The role of
ACTH4‑10Pro8‑Gly9‑Pro10
Rr Suzy Indharty
Department of Neurosurgery, University of Sumatera Utara, Medan, Indonesia
ABSTRACT
Background: Traumatic brain injury (TBI) is one of the major causes of death and disability. Apoptosis after TBI contributes
significantly to the final extent of tissue damage. The Bcl‑2 family proteins are important apoptosis modulators which
increased in injured neurons. Bcl‑2 has shown an antiapoptotic effect in rats and mice. ACTH4‑10Pro8‑Gly9‑Pro10 is a synthetic
short fragment of ACTH devoid of hormonal effects and has neuromodulatory properties. ACTH4‑10Pro8‑Gly9‑Pro10 has been
shown to increase levels of Bcl‑2 and BDNF in vitro as well as in vivo. It has been postulated that ACTH4‑10Pro8‑Gly9‑Pro10
will result in improved clinical outcome and reduce hospital length of stay. The goal of this study is to compare the effect
of standard therapy only with standard therapy and ACTH4‑10Pro8‑Gly9‑Pro10, the increase of Bcl‑2, and clinical outcome
with reduction of hospital stay.
Materials and Methods: Subjects of moderate head injury (MHI) with no indication of surgery were taken
consecutively (n = 40) and separated into two groups: standard treatment only and standard treatment combined with
ACTH4‑10Pro8‑Gly9‑Pro10. Blood samples were taken on day 1 and day 5 from each subject for measurements of Bcl‑2
concentration. Barthel Index and MMSE were measured, at discharge and hospital length of stay was noted.
Results: Forty subjects have been involved in this study, three subjects died in the standard therapy group, and one
subject in ACTH4‑10Pro8‑Gly9‑Pro10 group. Bcl‑2 serum level in standard therapy was 1.39 ± 0.75 ng/mL on day 1 and
1.48 ± 0.77 ng/mL on day 5. After treatment with ACTH4‑10Pro8‑Gly9‑Pro10, Bcl‑2 level was 1.39 ± 0.70 ng/mL on day 1
and 3.70 ± 1.02 ng/mL on day 5. The serum Bcl‑2 concentration was significantly increased with ACTH4‑10Pro8‑Gly9‑Pro10
therapy with shorter hospital length of stay (P
Asian Journal of Neurosurgery
HONORARY EDITOR IN CHIEF
Tetsuo Kanno
Fujita Health
University, Japan
EDITOR IN CHIEF
Yoko Kato
Fujita Health
University, Japan
EXECUTIVE EDITORS
Wai Hoe Ng
National
Neuroscience
Institute, Singapore
Atul Goel
K. E. M. Hospital,
India
Kostadin
Karagiozov
The Jikei University,
Japan
PUBLICATION & COORDINATING EDITOR
Abhishek Agrawal
Duke university and
medical center,
north carolina, USA
EDITORIAL ASSISTANT
Hiromi Peck Fujita Health University, Japan
EDITORIAL OFFICE:
Fujita Health University, Japan.
EDITORIAL BOARD:
Akira Ogawa
Gerardo
Katsuji Shima
Salman
Japan
Akira Teramoto
Japan
Ali Raja
Pakistan
Andrew H. Kaye
Australia
Atul Goel
India
Basant K. Misra
India
Basant Pant
Nepal
Batchuluun
Banzragch
Mongolia
Bob S. Carter
USA
Chandrashekar
E. Deopujari
India
Colvin Anaada
Samarasinge
Sri Lanka
Eka J.
Wahjoepramono
Indonesia
Endro Basuki
Indonesia
Fadzili Cheah
Abdullah
Malaysia
Feng Ling
China
Dizon
Legaspi
Philippines
Glavije
Amirjamshi
di
Pakistan
Hajime
Arai
Japan
Hee-Won
Jung
Korea
Hirotoshi
Sano
Japan
Im Sophorn
Cambodia
Imad N.
Kanaan
Saudi
Arabia
lvan Ng
Singapore
Iype
Cherian
Nepal
Jafri Malin
Dafuk HJ
Abdullah
Malaysia
Javaid
Iqbal
UAE
Jizong
Zhao
China
Julius July
Indonesia
Junichi
Mizuno
Japan
Kaoru
Kurisu
Japan
Japan
Liangfu Zhou
(WFNS:
second
delegate)
China
M. Necmettin
Pamir
Turkey
M.K. Kariev
Uzbekistan
Mehmet Zileli
Turkey
Marianne
Vonau
Australia
Michael
Lawton
USA
Moon-Chan
Kim
Korea
Mohsen Nouri
Iran
Muhammad
Anwar
Pakistan
Myat Thu
Myanmar
Nausher Alam
Bangladesh
Nho Vo Van
Vietnam
Nobuo
Hashimoto
Japan
Rahul Mally
India
Sharif
Pakistan
Suresh Nair
India
Takamasa
Kayama
Japan
Takaomi
Taira
Japan
Takeshi
Kawase
Japan
Tariq
Salahuddin
Pakistan
Toshiaki
Abe
Japan
Tsevegbat
Enkhbayar
Mongolia
Wai S. Poon
Hong Kong
Watanyoo
Prachayano
nt
Thailand
Yoichi
Katayama
Japan
YongKwang Tu
Taiwan
Yousef AI
Awadhi
Kuwait
Yuichi
Hirose
Japan
INTERNATIONAL ADVISORY BOARD:
Abass Amir Jamshidi
Iran
Abdeslam El
Khamlichi
Morocco
Ahmed Ammar
Saudi Arabia
Albert L. Rhoton
USA
Albino Bricolo
Italy
Alexander
N.Konovalov
Russia
Alexandru V. Ciurea
Romania
Ali F. Krisht
USA
Anil Nanda
USA
Apio Antunes
Brazil
Armando Basso
Argentina
Carolina Martins
Brazil
Chiristopher M.
Loftus
USA
Edward R. Laws Jr.
USA
Gail Rosseau
USA
Hamid Rahmat
Iran
Helmut Bertalanffy
Germany
Ibrahim Sbeih
Jordan
Jacques Brotchi
Belgium
James T. Rutka
Canada
Kazadi Kalangu
Zimbabwe
Laligam N.Sekhar
USA
Leonidas M. Quintana
Chile
Madjid Samii
Germany
Marcos Masini
Brazil
Maurice Choux
France
Moutaery, Khalaf
Al
Saudi Arabia
Nabil A. Rahman
Egypt
Ossama Al-Mefty
USA
Peter Black
USA
Richard Perrin
Canada
Robert F. Spetzler
USA
Roberto Heros
USA
Temitayo Shokunbi
Nigeria
Reviewer's List for AJNS
Abhishek Agrawal
Ajay Nand Jha
Ajith Thomas
Ali Krisht
Andrew Kaye
Anil Nanda
Apio Antunes
Ashok Kumar
Mahapatra
Atul Goel
Awadhesh Kumar
Jaiswal
Colvin Samarasinge
Chandrashekar E.
Deopujari
Edward R. Laws Jr.
Gerardo Legaspi
Gabriel Zada
Imad N. Kanaan
Ivan NG
Junichi Mizuno
Kai Frerichs
Ling Feng
Michael Lawton
Mitsuhiro Hasegawa
Mohsen Nouri
Muhammad Raji
Mahmud
Necmettin Pamir
Rakeshkumar Luhana
Suresh Nair
Wai Hoe NG
Yong-Kwang Tu
Yashbir Dewan
[Downloaded free from http://www.asianjns.org on Monday, August 31, 2015, IP: 114.125.9.86]
ORIGINAL ARTICLE
The increase of serum Bcl‑2 concentration in
moderate head injury outcome: The role of
ACTH4‑10Pro8‑Gly9‑Pro10
Rr Suzy Indharty
Department of Neurosurgery, University of Sumatera Utara, Medan, Indonesia
ABSTRACT
Background: Traumatic brain injury (TBI) is one of the major causes of death and disability. Apoptosis after TBI contributes
significantly to the final extent of tissue damage. The Bcl‑2 family proteins are important apoptosis modulators which
increased in injured neurons. Bcl‑2 has shown an antiapoptotic effect in rats and mice. ACTH4‑10Pro8‑Gly9‑Pro10 is a synthetic
short fragment of ACTH devoid of hormonal effects and has neuromodulatory properties. ACTH4‑10Pro8‑Gly9‑Pro10 has been
shown to increase levels of Bcl‑2 and BDNF in vitro as well as in vivo. It has been postulated that ACTH4‑10Pro8‑Gly9‑Pro10
will result in improved clinical outcome and reduce hospital length of stay. The goal of this study is to compare the effect
of standard therapy only with standard therapy and ACTH4‑10Pro8‑Gly9‑Pro10, the increase of Bcl‑2, and clinical outcome
with reduction of hospital stay.
Materials and Methods: Subjects of moderate head injury (MHI) with no indication of surgery were taken
consecutively (n = 40) and separated into two groups: standard treatment only and standard treatment combined with
ACTH4‑10Pro8‑Gly9‑Pro10. Blood samples were taken on day 1 and day 5 from each subject for measurements of Bcl‑2
concentration. Barthel Index and MMSE were measured, at discharge and hospital length of stay was noted.
Results: Forty subjects have been involved in this study, three subjects died in the standard therapy group, and one
subject in ACTH4‑10Pro8‑Gly9‑Pro10 group. Bcl‑2 serum level in standard therapy was 1.39 ± 0.75 ng/mL on day 1 and
1.48 ± 0.77 ng/mL on day 5. After treatment with ACTH4‑10Pro8‑Gly9‑Pro10, Bcl‑2 level was 1.39 ± 0.70 ng/mL on day 1
and 3.70 ± 1.02 ng/mL on day 5. The serum Bcl‑2 concentration was significantly increased with ACTH4‑10Pro8‑Gly9‑Pro10
therapy with shorter hospital length of stay (P